title: [Interdisciplinary and individualized therapy of prostate cancer : International prostate cancer symposium Bonn 2013 - challenges and targets].
abstract: Multimodal treatment of prostate cancer is based on specific staging via imaging, clinical parameters, tumor markers and histopathological grading. Risk-adapted therapy encompasses wait and see, active surveillance, surgical intervention, radiotherapy and hormone therapy. Some patients also need a combination of these treatment options. Even though clinical parameters guide the treatment plan, patient wishes and preferences are incorporated. Against this background leading basic research scientists, urologists, radiotherapists, epidemiologists and members of other associated disciplines discussed state of the art treatment concepts, innovative trial designs and translational research projects at the international meeting "Challenges and Chances in Prostate Cancer Research" organized by the German Cancer Aid (Deutsche Krebshilfe).
authors.affiliation: Urologie, Universitätsklinikum Freiburg, Freiburg, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Schwardt
authors.affiliation: RadioOnkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
authors.forename: J
authors.initials: J
authors.lastname: Debus
authors.affiliation: Bundesverband Prostatakrebs Selbsthilfe e.V., Gehrden, Deutschland.
authors.forename: G
authors.initials: G
authors.lastname: Feick
authors.affiliation: Urologische Universitätsklinik Heidelberg, Heidelberg, Deutschland.
authors.forename: B
authors.initials: B
authors.lastname: Hadaschik
authors.affiliation: Urologische Universitätsklinik Heidelberg, Heidelberg, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Hohenfellner
authors.affiliation: Urologie, Universitätsklinikum Freiburg, Freiburg, Deutschland.
authors.forename: R
authors.initials: R
authors.lastname: Schüle
authors.affiliation: Bundesverband Prostatakrebs Selbsthilfe e.V., Gehrden, Deutschland.
authors.forename: J-P
authors.initials: JP
authors.lastname: Zacharias
authors.affiliation: RadioOnkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland. stephanie.combs@tum.de.|Klinik und Poliklinik für RadioOnkologie und Strahlentherapie, Technische Universität München (TUM), Klinikum Rechts der Isar, Ismaninger Straße 22, 81675, München, Deutschland. stephanie.combs@tum.de.
authors.forename: S E
authors.initials: SE
authors.lastname: Combs
mesh_terms: D005858:Germany; D006801:Humans; D038622:Internationality; D008297:Male; D008495:Medical Oncology / Q000639:trends*; D010348:Patient Care Team / Q000639:trends*; D057285:Precision Medicine / Q000639:trends*; D011471:Prostatic Neoplasms / Q000628:therapy*; D014572:Urology / Q000639:trends*
keywords: Radiotherapy; Risk stratification; Subclassification, tumors; Therapy, operative; Therapy, stage-oriented